Journals / Gaziantep Tıp Dergisi / 2009 / Cilt: 15 - Sayı: 3

Appoaches to anti-HLA antibody profiles in patients waiting for renal re-transolantation

Renal re-transplantasyona hazırlanan hastaların anti-HLA antikor durumları ile ilgili yaklaşımlar

Pages
36–41
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Beyond all these, a newly developed computer algorithm, 'HLAMatchmaker' has changed the concept of transplantation possibility in highly sensitized patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:This review focuses on the mechanisms of anti-HLA antibody, development in patients waiting for a renal re-transplantation.
📊
Key Findings & Data:Pre'r existence or post transplant de novo production of these antibodies', have been found to contribute to renal allograft failure in years.
💡
Conclusion & Impact:Beyond all these, a newly developed computer algorithm, 'HLAMatchmaker' has changed the concept of transplantation possibility in highly sensitized patients.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

This review focuses on the mechanisms of anti-HLA antibody, development in patients waiting for a renal re-transplantation. Pre'r existence or post transplant de novo production of these antibodies', have been found to contribute to renal allograft failure in years. In addition to the detrimental effect of donor specific and. nolvdonor. specific artti-HLA antibodies on graft survival, many, researchers emphasized the effect of non-HLA antibodies (e.g.; anti-MICA antibodies); auto-antibodies (e.g.; anti-vimentin antibodies), allo-nephrectömy and combined liver-kidney transplantations on rejection processes. Beyond all these, a newly developed computer algorithm, 'HLAMatchmaker' has changed the concept of transplantation possibility in highly sensitized patients.

Özet

Bu derleme, renal re-transplantasyoha hazırlanan hastalarda anti-HLA antikor gelişim metonizmatarına^daklahmaktadır. Bu antikorların nakil öncesi dönemde var olması veya nakil spnrası de noyo üretj'mteri yıllar içerisinde graft yetmezliği ile sonlanır. Dönore özgü olan,ya da olmayan bu anti-HLA antikorların graft sağkalımı üzerine olan hasarlayıcı etkilerine ek olarak, pek çok çalışmada HLA dışı antikorlar (örn; anti-MICA antikorları), oto-antikorlar, allo-nefrektomi ve karaciğer ve böbreğin birlikte naklinin rejeksiyon süreçlerine etkilerini incelenmiştir.,Bunların yanı sıra, son yıllarda geliştirilen ve 'HLAMatchmaker' olarak adlandırılan bir bilgisayar algoritması, bekleme listelerinde uzun yıllar bekleyen ve nakil olma ihtimalleri çok düşük olan yüksek oranda sensitize bireyler için umut ışığı olma özelliğindedir.

🔖

Cite This Article

ÇARİN, M. N., KARAHAN, G. E., OĞUZ, F. S. (2022). Appoaches to anti-HLA antibody profiles in patients waiting for renal re-transolantation. Gaziantep Tıp Dergisi, Cilt: 15 - Sayı: 3, 36–41. https://ajindex.com/articles/518994

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Morris PJ, Mickey MR, Singal DP, Terasaki PI. Serotyping for homotransplantations. XXII. Specificity of cytotoxic antibodies developing after renal transplantation. Br Med J. 1969;l:758-759. 2.Jeannet M, Pinn VW, Flax MH, Russell PS. Humoral antibodies in renal alotransplantation in man. N Engl J Med. 1970;282:111-117. 3.McKenna RM, Takemoto SK, Terasaki PI. Anti-HLA antibodies after solid organ transplantation. Transplantation. 2000;69:319-326. 4.Terasaki P. Humoral theory of transplantation. Am J Transplant. 2003;3:665-673. 5.Kaufman A, de Souza Pontes LF, Queiroz Marques MT. Analysis of AHG-PRA and ELISA-PRA in kidney transplant patients with acute rejection episodes. Transplant Immunol. 2003;ll:175-178. 6.Crespo M, Lozano M, Sole M. Diagnosis and treatment of acute humoral rejection after kidney transplantation: preliminary experience. Transplant Proc. 2003;35:1677-1678. 7.Fernandez-Fresnedo G, Pastor JM, Lopez-Hoyos M. Relationship of donor-specific class-I anti-HLA antibodies detected by ELISA after kidney transplantation on the development of acute rejection and graft survival. Nephrol Dial Transplant 2003; 18:990-995. 8.Pelletier RP, Hennessy PK, Adams PW, VanBuskirk AM, Ferguson RM, Orosz CG. Clinical significance of MHC-reactive alloantibodies that develop after kidney or kidney-pancreas transplantation. Am J Transplant. 2002;2:134-141. 9.Panigrahi A, Deka R, Bhowmik D, Tiwari SC, Mehra NK. Immunological monitoring of posttransplant allograft sensitization following living related donor renal transplantation. Transplant Proc. 2004;36:1336-1339. lO.Crespo M, Pascual M, Tolkoff-Rubin Nal. Acute humoral rejection in renal allograft recipients: I.Incidence, serology and clinical characteristics. Transplantation. 2001:71:652-658. ll.Varnavidou-Nicolaidou A, Doxiadis II, Iniotaki-Theodoraki A, Patargias T, Stavropoulos-Giokas C, Kyriakides GK. HLA class I donor-specific triplet antibodies detected after renal transplantation. Transplant Proc. 2004;36:1732-1734. 12.Hourmant M, Cesbron-Gautier A, Terasaki P. Frequency and clinical implication of development of donor-specific and non-donor specific HLA antibodies after kidney transplantation. J Am Soc Nephrol. 2005; 16:2804-2812. 13.Sumitran-Holgersson S. HLA-specific alloantibodies and renal graft outcome. Nephrol Dial Transplant. 2001; 16:897-904. 14.Class FHJ and van Roood JJ. The hyperimmunized patient: from sensitziation toward transplantation. Transplant International. 1988; 1:53-57. 15.Palmer A,